Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Valneva and Pfizer Announce Initiation of Phase 2 Study for Lyme Disease Vaccine Candidate
VALNEVAMarch 8, 2021 GMT
The Phase 2 study will include both adult and pediatric subjects with an aim to support acceleration of the vaccine candidate’s pediatric program
VLA15 will be tested at two different schedules (Month 0-2-6 or Month 0-6) receiving the selected dose of 180µg
VLA15 is the only Lyme disease vaccine candidate in active clinical development
Saint-Herblain (France) and New York, NY, March 8, 2021 – Valneva SE (“Valneva”), a specialty vaccine company focused on prevention of diseases with major unmet needs, and Pfizer Inc. (NYSE: PFE) today announced initiation of study VLA15-221. The VLA15-221 study builds on previous positive Phase 2 studies, incorporates new dose regimens and is anticipated to be the final Phase 2 study readout before a decision to progress int
Valneva and Pfizer Announce Initiation of Phase 2 Study for Lyme Disease Vaccine Candidate
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Valneva Initiates Phase 3 Clinical Lot Consistency Study for its Single-Shot Chikungunya Vaccine Candidate
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
FLUIDRA: Fluidra continues in the FTSE4Good
CDP also reflects Fluidra s commitment to sustainable practices
9 February 2021 - Fluidra, a global leader in the pool and wellness equipment sector, will remain on the FTSE4Good Index Series for one more year. This selection is designed to enable investors to identify businesses that comply with the best practices on environmental, social and corporate governance (ESG) matters.
The company joined this index for the first time in 2009 and subsequently left and rejoined because of its overall capitalization volume. In order to be part of the FTSE4Good, certain levels of capitalization must be reached and a number of ESG standards met. The FTSE4Good is overseen by an independent committee of experts in these fields and market professionals.